Wednesday, April 21News That Matters

Tag: TransMedics

TransMedics Announces Whisk FDA Advisory Committee Vote For OCS Coronary heart Arrangement

TransMedics Announces Whisk FDA Advisory Committee Vote For OCS Coronary heart Arrangement

Latest
ANDOVER, Mass., April 6, 2021 /PRNewswire/ -- TransMedics Team, Inc. ("TransMedics") (Nasdaq: TMDX), a clinical know-how company that is remodeling organ transplant therapy for sufferers with raze-stage lung, coronary heart, and liver failure, launched nowadays that after the evaluation of TransMedics' clinical evidence from the OCS Coronary heart EXPAND trial, the associated Persisted Get entry to Protocol ("CAP") outcomes, in addition to to the OCS Coronary heart PROCEED II trial, the Circulatory Methods Instrument Advisory Panel convened by the U.S. Meals and Drug Administration ("FDA") has issued a certain vote in purple meat up of approval of the OCS Coronary heart Arrangement to the FDA's Situation of business of Effectively being Abilities 2 (Cardiovascular Devices). The panel vot...